Sir2 is an NAD-dependent deacetylase that connects metabolism with longevity in yeast, worms and flies. Mammals contain seven homologs of yeast Sir2, SIRT1-7. Here, we review recent findings demonstrating the role of these mammalian sirtuins as regulators of physiology, calorie restriction, and aging. The current findings sharpen our understanding of sirtuins as potential pharmacological targets to treat the major diseases of aging.
1999; Tanny et al. 1999) . Subsequent reports revealed that yeast and mammalian sirtuins catalyze a novel and robust reaction, NAD-dependent histone deacetylation, unavoidably linking Sir2 activity with metabolism (Imai et al. 2000; Landry et al. 2000; Smith et al. 2000) . Mechanistically, ADP-ribosylation and deacetylation reactions by sirtuins are similar because they cleave NAD in each reaction cycle ( Fig. 1) (Grubisha et al. 2005) . During each cycle, deacetylation generates the novel metabolites, 2Ј and 3Ј-O-acetyl-ADP-ribose (Tanner et al. 2000; Sauve et al. 2001; Tanny and Moazed 2001) , which may be important regulators of physiology (Grubisha et al. 2006 ). Today, more than a dozen nonhistone deacetylation substrates are known, several of which are described below.
Calorie restriction (CR) is a dietary regimen that extends the lifespan of every organism tested to date. Specifically, CR extends the lifespan of yeast (Lin et al. 2002) , spiders (Austad 1989) , flies (Loeb and Northrop 1917) , fish (Comfort 1963) , and rodents (McCay et al. 1935; Austad 1989) . Sir2 is required for lifespan extension by CR in yeast, worms, and flies (Lin et al. 2000; Rogina and Helfand 2004; Wang and Tissenbaum 2006) . In yeast, CR (0.5% glucose), was previously shown to increase mitochondrial function and to up-regulate SIR2 activity (Lin et al. 2002 . However, in this case, the mitochondrial activation is SIR2-independent, suggesting that it lies upstream of SIR2. A more severe CR regimen (0.05% glucose) extends yeast replicative lifespan by a different mechanism that is apparently independent of both SIR2 and mitochondrial respiration (Kaeberlein et al. 2004 (Kaeberlein et al. , 2005 . Finally, SIR2 has no effect on yeast survival under starvation conditions, and appears to actually reduce survival of certain exceptionally long-lived mutant strains (Fabrizio et al. 2005) .
Do sirtuins regulate human longevity? Mammals have seven Sir2 homologs (sirtuins, SIRT1-7). These proteins have a highly conserved NAD-dependent sirtuin core domain, first identified in the founding yeast SIR2 protein, making them good candidates as lifespan regulators (Frye 2000) . As highlighted in this review, mammalian sirtuins have diverse cellular locations, target multiple substrates, and affect a broad range of cellular functions (Table  1) . In this review, we emphasize an emerging theme in the field of aging-the regulation of oxidative stress, DNA damage, and metabolism by mammalian sirtuins.
Nuclear sirtuins
Three mammalian sirtuins (SIRT1, SIRT6, and SIRT7) are localized to the nucleus. SIRT1 is most extensively studied, has more than a dozen known substrates, and is a guardian against cellular oxidative stress and DNA damage. Moreover, SIRT1 plays a prominent role in metabolic tissues, such as pancreas, fat, and liver. SIRT6 and SIRT7 may also be important regulators of DNA damage and metabolism, respectively.
SIRT1 substrates in mammals
While a role for mammalian sirtuins in lifespan regulation has not been directly determined, evidence suggests that the Sir2 ortholog, SIRT1, may regulate many physiological processes known to be affected during aging and which are altered by CR (Fig. 2) . SIRT1 deacetylates a large number of substrates, including p53, Ku70, NF-B, and forkhead proteins to affect stress resistance in cells (Luo et al. 2001; Vaziri et al. 2001; Brunet et al. 2004; Cohen et al. 2004; Motta et al. 2004; Yeung et al. 2004) , which may relate to the observed stress resistance conferred by CR. SIRT1 also regulates the activities of the nuclear receptor PPAR␥ and PGC-␣ (see below) to influence differentiation of muscle cells, adipogenesis, fat storage in white adipose tissue, and metabolism in the liver, suggesting a possible connection between this sirtuin and diets that promote leanness and longevity (Fulco et al. 2003; Picard et al. 2004; Rodgers et al. 2005) . The observed induction of SIRT1 protein during CR is consistent with this idea Nisoli et al. 2005) . These activities link SIRT1 to known physiological effects of CR, and suggest that this sirtuin may help mediate CR in mice.
SIRT1 regulation of insulin and glucose homeostasis
A critical component of the physiology of CR is increased insulin sensitivity and corresponding reductions in blood glucose and insulin levels (Barzilai et al. 1998; Dhahbi et al. 2001) . Pancreatic ␤-cells help to maintain glucose homeostasis by secreting insulin in response to glucose. Metabolism of glucose in these cells by glycolysis generates pyruvate, which enters mitochondria where it can be converted to CO 2 by the TCA cycle. NADH made by this metabolic process drives electron transport and ATP synthesis. The increased ATP/ADP ratio causes closure of K ATP channels and depolarizes the plasma membrane leading to an influx of Ca 2+ , which triggers fusion of secretory vesicles containing insulin to the cell membrane.
Two recent studies in mice have demonstrated that SIRT1 positively regulates glucose-stimulated insulin secretion in pancreatic ␤-cells (Moynihan et al. 2005; Bordone et al. 2006 ). ␤-Cell-specific SIRT1-overexpressing (BESTO) mice demonstrate increased insulin secretion in response to glucose (Moynihan et al. 2005) . Conversely, SIRT1 −/− mice or their isolated islets show blunted insulin secretion (Bordone et al. 2006) . Both studies find that SIRT1 represses transcription of the mitochondrial uncoupling protein UCP-2 gene, which uncouples mitochondrial respiration from ATP production and reduces the proton gradient across the mitochondrial membrane. Thus, by blocking UCP-2 function, SIRT1 promotes more efficient energy generation. Indeed, BESTO islets demonstrate higher ATP levels (Moynihan et al. 2005) , while islets from SIRT1 knockout (KO) mice do not elevate ATP production in response to glucose (Bordone et al. 2006 ). Interestingly, SIRT1-mediated repression of UCP-2 is alleviated by acute food deprivation (Bordone et al. 2006) , which may further dampen ATP synthesis and the insulin responsiveness of ␤-cells during starvation. While SIRT1 protein level is not affected by this condition, there is a decrease in the NAD/NADH ratio, which may reduce SIRT1 activity in pancreas (Bordone et al. 2006) . The presence of UCP-2 in fasted animals may also ease the transition to metabolic activity after the next feeding and prevent hyperpolarization of the mitochondrial membrane and the corresponding production of reactive oxygen species. While these studies demonstrate that SIRT1 activity may be down-regulated in ␤-cells during fasting, it is not known whether SIRT1 regulates insulin secretion during CR, or plays any role in pathologies demonstrating impaired insulin secretion. Another study raises the possibility that SIRT1 promotes the survival of pancreatic ␤-cells during oxidative stress (Kitamura et al. 2005) . In stressed ␤-cells, the forkhead protein FOXO1 moves into the nucleus and activates the ␤-cell transcription factors, NeuroD and MafA, and provides stress resistance. As described above, SIRT1 binds to and regulates forkhead transcription factors both negatively and positively (Brunet et al. 2004; Motta et al. 2004 ). Kitamura et al. (2005) show that nuclear FOXO1 associates with SIRT1 in PML (promyelocytic leukemia) bodies in stressed cells. They suggest that SIRT1 deacetylates FOXO1 at that location to activate the protein and provide stress resistance (Accili and Arden 2004) . This process bears similarity to sir-2.1 in C. elegans discussed above, which functions as a coactivator of the DAF-16 protein after it translocates to the nucleus in oxidatively or heat stressed worms (Berdichevsky et al. 2006) .
Glucose homeostasis is maintained by the liver, in addition to pancreatic ␤-cells, in response to changing nutrient conditions. During fasting, hepatocytes induce gluconeogenesis to supply other tissues with glucose. Several new studies have revealed that this nutrient response is under tight control of SIRT1 activity, providing another link between SIRT1 and metabolism. In cultured hepatocytes, SIRT1 interacts with and deacetylates nuclear FOXO1, promoting FOXO1-dependent transcription of hepatic gluconeogenic genes upon stress (Frescas et al. 2005 ). In the liver, the transcriptional coactivator PGC-1␣ also drives expression of the gluconeogenic pathway. SIRT1 deacetylates and activates PGC-1␣ to coordinate the increase in expression of gluconeogenic genes with the repression of glycolytic genes during fasting (Rodgers et al. 2005) . However, in a neuronal cell line, overexpression of SIRT1 decreases the activity of PGC1-␣ and mitochondrial function (Nemoto et al. 2005) , suggesting that the relationship between SIRT1 and PGC-1␣ may be complex.
SIRT1 and neuron function
SIRT1 has also been linked to the survival of neurons. It is interesting to note that CR protects against neurodegenerative pathology in mouse models for Alzheimer's (Zhu et al. 1999; Patel et al. 2005 ) and Parkinson's (Duan and Mattson 1999) . SIRT1 can promote survival in cultured neuronal cells as an antiapoptotic factor, perhaps through down-regulating the proapoptotic factors, p53 (Luo et al. 2001; Vaziri et al. 2001 ) and FOXO (Brunet et al. 2004; Motta et al. 2004) . Even more interestingly, SIRT1 may be involved in the axonal protection observed in the Wallerian strain of mice (Araki et al. 2004) , which have a translocation that increases levels of the NAD biosynthetic enzyme nicotinamide mononucleotide adenylyl-transferase 1 and renders peripheral axons more stable after a neuronal insult. Indeed, NAD itself provides protection to axons in cultured dorsal root ganglia. One study shows that the effects of NAD and the Wallerian strain are dependent on SIRT1, leading to the conclusion that this sirtuin is neuroprotective (Araki et al. 2004 ). However, another study did not observe a difference in the response of dorsal root ganglion from SIRT1 KO mice . It is interesting to note that the time course of axonal degradation in the two studies is different, suggesting that there may be two different neuroprotective processes induced by NADone dependent on SIRT1 and one not. Future studies should resolve these apparent experimental discrepancies.
SIR2 orthologs can also protect against neuronal dysfunction due to polyglutamine toxicity in C. elegans and mammalian cells (Parker et al. 2005) . One study shows that neurotoxicity in worms is spared by the age-1 mutation, which reduces insulin-like signaling (Morley et al. 2002) , or in a transgenic strain overexpressing sir-2.1 (Parker et al. 2005) . Like the effects of the age-1 or sir-2.1 transgenes in extending lifespan, neuroprotection requires the forkhead protein DAF-16 (Parker et al. 2005) . As might be expected, polyglutamine toxicity is exacerbated in daf-16 or sir-2.1 mutants. The putative SIR2-activating polyphenol, resveratrol (Howitz et al. 2003) , also protects against cell death in striatal neurons with the Huntingtons Disease allele htt (109Q) (Parker et al. 2005) . Finally, ␤-amyloid-induced death of microglia is spared by overexpression of SIRT1 or resveratrol treatment (J. . In toto, the above studies raise the possibility that activation of SIRT1 may be a novel strategy to protect against neurodegenerative diseases. We note, however, that the protective effect of SIRT1 may not be universal in all cell types, since SIRT1 −/− mouse embryonic fibroblasts (MEFs) actually survive 
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SIRT1 and CR
The above studies suggest that important physiological processes triggered by CR in mammals are regulated by SIRT1, making it vital to know whether mammalian sirtuins also regulate changes during CR. Recent experiments have directly related SIRT1 function to CR in mice. CR induces the endothelial nitric oxide synthase (eNOS), and results in an increase in mitochondrial biogenesis (Nisoli et al. 2005) . Moreover, this mitochondrial induction by CR does not occur in eNOS deficient mice. Interestingly, the SIRT1 gene is activated by NO in vivo and in vitro (Nisoli et al. 2005) , tracing a pathway in which CR induces NO production and activates mitochondrial biogenesis and SIRT1.
A more direct demonstration of the requirement of SIRT1 in CR involved placing SIRT1 KO mice on this diet (D. . Although the KO mice show changes in blood glucose, triglycerides, and IGF-1 similar to wild-type controls, there is a large difference in one interesting output of CR. Wild-type mice show a fivefold to 10-fold increase in physical activity, which has been observed previously and may represent a foraging instinct induced by food insufficiency, but KO mice do not display any increase in activity. SIRT1 KO mice move as well or better than wild type when challenged by other means; i.e., rotarod or treadmill. This study indicates the first requirement for SIRT1 for at least one phenotype triggered by mammalian CR.
SIRT6 regulates DNA repair
SIRT6 is a nuclear protein widely expressed in mouse tissues (Liszt et al. 2005; Michishita et al. 2005) . Original reports demonstrated that SIRT6 has a weak to absent in vitro deacetylate activity (North et al. 2003; Liszt et al. 2005) . However, SIRT6 has also been shown to demonstrate a robust auto-ADP-ribosyltransferase activity (Liszt et al. 2005) .
Recent work has provided insight into the diverse physiological functions of SIRT6 . SIRT6 KO mice display premature aging symptoms, including loss of subcutaneous fat and decreased bone density, and die within 4 wk after birth. These phenotypes contrast with those of SIRT1 KO animals, which are postnatal lethal on an inbred strain (Cheng et al. 2003; McBurney et al. 2003) . Outbred SIRT1 KO animals can survive into adulthood, but demonstrate a severe phenotype, including small size, delayed bone mineralization, defective skeletal closure, delayed eyelid opening, and sterility (Cheng et al. 2003; McBurney et al. 2003; Lemieux et al. 2005) .
SIRT6 KO mice exhibit a deficiency in one specific form of DNA repair, the base excision repair (BER) . MEFs lacking SIRT6 demonstrate impaired proliferation and enhanced sensitivity to DNAdamaging agents. SIRT6 KO MEFs demonstrate genomic instability in the form of chromosomal translocations, fragments, gaps, and detached centromeres. These defects can be rescued by overexpression of the DNA polymerase involved in BER, Pol␤. Furthermore, SIRT6 KO MEFs exhibit normal cell cycle checkpoints, end-joining, and double-strand break DNA repair. How SIRT6 regulates BER is still unknown. One might hypothesize that this sirtuin ADP-ribosylates a substrate protein involved in BER, which could be a component of the repair machinery or the chromatin at the site of DNA damage.
SIRT6 KO mice also display interesting metabolic phenotypes: low levels of circulating IGF-1 and hypoglycemia that becomes progressively more severe with age ). It will be interesting to know whether these metabolic changes are due to a direct role for SIRT6 in regulating IGF-1 and glucose homeostasis or are an indirect consequence of DNA damage that accumulates in these mutant mice.
SIRT7 promotes rRNA transcription

SIRT7 localizes to the nucleolus of human cells (Michishita et al. 2005; Ford et al. 2006). Interestingly, SIRT7
expression correlates with growth (Ford et al. 2006 )-it is abundant in tissues with high proliferation, such as liver, spleen, and testes. By contrast, SIRT7 expression is absent or low in nonproliferating tissues, like heart, brain, and muscle.
Recent work has shown that SIRT7 may regulate cellular growth and metabolism (Ford et al. 2006 ). In the nucleolus, SIRT7 associates with rDNA and interacts with RNA polymerase I (Pol I). Overexpressing SIRT7 increases rRNA transcription and RNA inhibition of SIRT7 decreases transcription, showing that this sirtuin activates Pol I transcription (Ford et al. 2006 ).
An NAD-dependent deacetylase activity has not been observed for SIRT7 (North et al. 2003) , but the amino acid residues that bind NAD in the conserved sirtuin core domain are required for SIRT7 activity (Ford et al. 2006) , suggesting a role for NAD-dependent regulation. SIRT7 thus appears to regulate cell growth and metabolism in response to changing metabolic conditions by driving ribosome biogenesis in dividing cells. It is interesting that both SIRT7, as an activator of rRNA transcription, and SIRT1, as an inhibitor of p53 and FOXO, have features that are progrowth and prosurvival for cells.
Cytoplasmic sirtuins
To date, only SIRT2 is reported to be localized mainly in the cytoplasm (North et al. 2003; Michishita et al. 2005) , while a fraction of SIRT2 is nuclear (North et al. 2003) . Interestingly, SIRT1 is also reported to be a cytoplasmic protein in pancreatic ␣-cells (Imai et al. 2000) . These findings lead us to speculate that mammalian sirtuins may shuttle between the nucleus and cytoplasm, depending on cell type or environmental stimuli.
SIRT2
Mammalian SIRT2 is a predominantly cytoplasmic protein (Dryden et al. 2003; North et al. 2003; Michishita et al. 2005) , colocalizes with tubulin, and can deacetylate a number of substrates in vitro, including ␣-tubulin (North et al. 2003) and histones, although the physiological consequences of ␣-tubulin deacetylation by SIRT2
are not yet clear. The yeast ortholog of SIRT2, Hst2, can function in parallel to SIR2 in certain strains with respect to lifespan extension and rDNA silencing (Lamming et al. 2005) . Therefore, it will be interesting to determine the lifespan of SIRT2-overexpressing mice, or to determine whether CR is partly mediated by SIRT2 using SIRT2 KO animals.
Cell culture studies demonstrate SIRT2 may be important in regulating mammalian cell cycle. SIRT2 protein levels increase during mitotic phase of the cell cycle and its overexpression delays mitosis (Dryden et al. 2003) . Consistent with the idea that SIRT2 may restrain the cell cycle, expression of this sirtuin is down-regulated in human gliomas, compared with normal brain samples (Hiratsuka et al. 2003) . SIRT2 colocalizes with chromatin during the G 2 /M transition, a period in which the nuclear membrane has broken down (Vaquero et al. 2006) . Both SIRT2 and Hst2 show a preference for deacetylating histone H4 at Lys16 in vitro, and SIRT2 KO mouse embryonic fibroblasts (MEFs) display hyperacetylated H4K16 during mitosis. Since SIRT1 also deacetylates H4K16, SIRT2 and SIRT1 may function redundantly, at least during the M phase of the cell cycle. SIRT2 may also regulate other phases of the cell cycle, since G 1 is extended and S is shortened in SIRT2 −/− MEFs.
Mitochondrial sirtuins-key regulators of metabolism
Mitochondria are dynamic organelles that regulate nutrient utilization to provide the cell with energy even during dramatic changes in diet and development. Mitochondria also play a central role in mediating apoptosis in response to DNA damage or oxidative stress. These organelles are the primary site of reactive oxygen species (ROS) generation within the cell, and increased oxidative damage is proposed to be one cause of mammalian aging (Harmon 1956; Wallace 2005) .
The mitochondrial localization of SIRT3-5 is especially intriguing because mitochondrial dysfunction is associated with mammalian aging and many diseases, including diabetes, neurodegenerative diseases, and cancer (Wallace 2005) . Do mitochondrial sirtuins regulate metabolism, the oxidative stress response, and ultimately, mammalian aging? It is important to note that although SIRT1 is not itself physically associated with mitochondria, as described above, it also impacts mitochondrial functions. Lifespan analysis of animals with varying SIRT3-5 level has not been performed; however, there is growing evidence linking mitochondrial sirtuins with regulating energy usage and even human lifespan.
SIRT3
SIRT3 was the first sirtuin shown to be localized to the mitochondria of mammalian cells (Onyango et al. 2002; Schwer et al. 2002; Michishita et al. 2005) . SIRT3 is localized to the mitochondrial matrix and cleavage of its signal sequence is necessary for enzymatic activity (Schwer et al. 2002) . SIRT3 deacetylates multiple substrates in vitro including histone peptides (Onyango et al. 2002; Schwer et al. 2002) and tubulin (North et al. 2003) .
The biological functions of SIRT3 are beginning to emerge. SIRT3 is expressed in brown adipose tissue and induced by cold exposure (Shi et al. 2005) . Moreover, the deacetylase activity of SIRT3 is reported to be required for the induction of uncoupling protein 1 (UCP-1). SIRT3 also appears to regulate mitochondrial functions, as its overexpression increases respiration, while decreasing reactive oxygen species production (Shi et al. 2005) .
Two recent studies demonstrate that SIRT3 may regulate the activity of acetyl-CoA synthetase (AceCS) (Hallows et al. 2006; Schwer et al. 2006) , representing a striking, conserved activity with the bacterial sirtuin, cobB (Tsang and Escalante-Semerena 1998; Starai et al. 2002) . AceCS uses acetate, CoA, and ATP to form acetyl-CoA, which is an intermediate in the TCA cycle, and is also required for cholesterol and fatty acid synthesis. Acetylation of mitochondrial AceCS (AceCS2) inactivates the enzyme, whereas deacetylation by SIRT3 activates it. Interestingly, SIRT1 can deacetylate and activate the cytosolic form of AceCS (AceCS1). These data suggest that SIRT3 may play a role in regulating the entry of carbons from acetate into central metabolism. It will be important to assess the in vivo relevance of these findings using SIRT3 −/− mice. In sum, SIRT3 may be especially important under conditions of energy limitation-i.e., during fasting or CR to ensure full incorporation of dietary or ketone-derived acetate into metabolism.
In human population studies, polymorphisms within the SIRT3 gene have been linked to longevity. The G477T transversion, while not affecting the amino acid sequence, associates with survivalship of elderly males (Rose et al. 2003 ) and may signify a haplotype promoting longevity. The same group found that a variable number of tandem repeats (VNTR) enhancer within SIRT3 also associates with lifespans >90 yr (Bellizzi et al. 2005) . These findings will need to be validated in larger samples, but suggest that the expression of SIRT3 may promote longevity in humans and raise the importance of performing lifespan experiments in mice that overexpress or lack SIRT3.
SIRT4
SIRT4 is another mitochondrial protein (Michishita et al. 2005 ) that regulates energy usage. SIRT4 lacks detectable deacetylase activity (North et al. 2003 ), but demon-strates ADP-ribosyltransferase activity. SIRT4 plays an important role in regulating amino acid-stimulated insulin secretion (AASIS) in pancreatic ␤-cells by ADPribosylating and inhibiting glutamate dehydrogenase (GDH) ( Fig. 3 ; Haigis et al. 2006) . GDH converts glutamate into ␣-ketoglutarate, a TCA cycle intermediate. GDH-activating mutations cause hyperinsulinism in humans showing that this enzyme regulates insulin secretion by gating the flow of amino acids into central metabolism in ␤-cells (Stanley et al. 1998) . SIRT4 KO mice have no gross abnormalities, but display higher GDH activity and higher levels of circulating insulin. SIRT4 KO mice have elevated AASIS, and strikingly, unlike wild type, they secrete insulin in response to glutamine.
SIRT4 may also connect insulin secretion with CR. Islets isolated from CR mice demonstrate increased AA-SIS similar to islets from ad libitum fed SIRT4 KO mice (Haigis et al. 2006) . Down-regulation of SIRT4 during CR appears to mediate this effect because GDH from islets of CR mice is less ADP-ribosylated and more active than GDH from control islets. A similar change in GDH is found in the liver of CR mice. We suggest that SIRT4 coordinates a physiological response in liver and ␤-cells during energy limitation (Fig. 3) . In the liver, the flow of carbon from amino acids into gluconeogenesis would be increased, and in ␤-cells the ability amino acids to trigger insulin secretion would be elevated. Since overall insulin secretion is clearly lower during CR because of reduced blood glucose, it seems likely that the spectrum of insulin secretagogues is thus shifted from carbohydrates to amino acids.
We note that the apparent down-regulation of SIRT4 during CR in ␤-cells and liver goes against the expectation that sirtuin activity should increase during this dietary regimen. However, it is consistent with the observed reduction in the NAD/NADH ratio in liver of CR mice (Hagopian et al. 2003b ) and the observed increase in gluconeogenesis in this organ (Hagopian et al. 2003a) . We suggest that a shift from carbohydrates to fat as preferred energy source during CR may help drive down the NAD/ NADH ratio in these tissues and thus moderate these metabolic changes.
SIRT5
SIRT5 remains the least characterized sirtuin to date. SIRT5 is described as a mitochondrial protein (Michishita et al. 2005 ) and has weak deacetylase activity (North et al. 2003 ), but does not appear to possess an ADP-ribosyltransferase activity (Haigis et al. 2006) . Possible physiological substrates of SIRT5 and its role in mammalian cells are not yet known.
Summary and perspective
Sirtuins have emerged as key antiaging genes in model organisms. The NAD-dependence of these proteins links them unavoidably to the metabolic activity of cells. In several organisms, sirtuins have been shown to be regulated by and to mediate the effects of the dietary regimen CR. Moreover, mammalian sirtuins have been implicated in stress resistance and numerous metabolic pathways, including adipogenesis, gluconeogenesis, and insulin and glucose homeostasis.
While it may be years before we know whether sirtuins regulate mammalian lifespan, current data suggests that these proteins are regulated by diet and in turn, regulate multiple facets of physiology, making them interesting therapeutic targets for metabolic and neurodegenerative diseases (Fig. 4) . Several important questions need to be resolved to improve our understanding of sirtuin biology and their therapeutic potential. First, what other functions can be ascribed to the SIRT1-7 proteins? We predict that like SIRT1, SIRT2-7 will have multiple targets and may affect many biologies. Second, how is sirtuin function regulated? Two known mechanisms of sirtuin regulation are (1) its protein induction during CR or fasting Nisoli et al. 2005; Rodgers et al. 2005) and (2) regulation by metabolites NAD, NADH, and nicotinamide (Anderson et al. 2003a,b; Lin et al. 2004) . Third, are all seven sirtuins regulated in the same direction by CR in any given tissue? If the NAD/ NADH ratio (or nicotinamide concentration) is a primary determinant of regulation, it is possible that all seven sirtuins will be regulated similarly by CR in a given cell, since the NAD/NADH ratio has the potential to equilibrate throughout cellular compartments by shuttle systems. Another likely possibility is that the concentration of NAD and its metabolites are regulated compartmentally. For example, enzymes involved in NAD biosynthesis are found in the nucleus, peroxisome, Golgi apparatus, mitochondria, and cytoplasm (Yang et al. 2006) . Fourth, does the NAD/NADH ratio change in different directions depending on the tissue in response to CR? This possibility seems likely, since CR induces distinct metabolic changes in different tissues (e.g., activation of gluconeogenesis in liver and fat loss in white adipose tissue). Moreover, fasting decreases SIRT1 activity in the pancreas (Bordone et al. 2006) , while increasing its activity in the liver (Rodgers et al. 2005) . This last question is important, because if sirtuins are activated by CR in some tissues but repressed in others, genetically altered mice (i.e., SIRT knockout or overexpressed) or pharmacological interventions to activate or repress a sirtuin systemically (see below) may mimic CR in only a segmental fashion.
In the next few years the answers to these and other questions will auger how well pharmacological agents that target sirtuins will serve as CR mimetics. This path of drug intervention is especially compelling, because CR mitigates many major diseases in rodent models. We can hope that new classes of drugs are on the horizon to deliver broad benefits for these diseases.
